您的位置: 首页 > 农业专利 > 详情页

Combination of STING agonist and IL-15/IL15-Ra for the treatment of cancer
专利权人:
Aduro Biotech Inc.;Novartis AG
发明人:
KOPP, Nadja,LEONG, Justin,MCKENNA, Jeffrey,NDUBAKU, Chudi Obioma,PINZON-ORTIZ, Maria,RONG, Xianhui,SULLIVAN, Ryan
申请号:
AU2019213843
公开号:
AU2019213843A1
申请日:
2019.02.01
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
The present disclosure relates to a pharmaceutical composition comprising a STING agonist molecule in combination with an IL-15/IL-15Ra complex. The present combination can be administered independently or separately, in a quantity which is therapeutically effective for the treatment of cancer. Also provided is the use of such a combination for the manufacture of a medicament; the use of such a combination as a medicine; a kit of parts comprising such a combination; and a method of treatment of such a combination.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充